Messenger RNA (mRNA) is a groundbreaking platform for vaccines and therapeutics. However, during in-vitro transcription (IVT), double-stranded RNA (dsRNA) can form as an unwanted by-product. Even trace amounts of dsRNA can trigger innate immune responses, reduce translation efficiency, and compromise product performance.
To ensure product safety and meet rising regulatory expectations, Abnova provides a dsRNA impurity analysis. This service combines qualitative detection (Dot Blot) and quantitative measurement (ELISA) to accurately assess dsRNA contamination in mRNA products, supporting research, process development, and quality assurance.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
||||||||||||||||||
|
Comparison of dsRNA Levels in Unpurified and Purified mRNA by Dot Blot and ELISA |
||||||||||||||||||
|
Dot Blot |
||||||||||||||||||
|
||||||||||||||||||
|
ELISA |
||||||||||||||||||
|
||||||||||||||||||
- oem@abnova.com
- TW : +886-2-8751-1888 / USA : +1(857) 639 0367 / Korea : +82-1670-5911.



